SEL1L2
gene geneOn this page
Also known as DKFZp434C1826
Summary
SEL1L2 (SEL1L2 adaptor subunit of SYVN1 ubiquitin ligase, HGNC:15897) is a protein-coding gene on chromosome 20p12.1, encoding Protein sel-1 homolog 2 (Q5TEA6).
Predicted to be involved in ERAD pathway. Located in cilium and nuclear speck.
Source: NCBI Gene 80343 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 14 total — 1 pathogenic
- MANE Select transcript:
NM_025229
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15897 |
| Approved symbol | SEL1L2 |
| Name | SEL1L2 adaptor subunit of SYVN1 ubiquitin ligase |
| Location | 20p12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp434C1826 |
| Ensembl gene | ENSG00000101251 |
| Ensembl biotype | protein_coding |
| OMIM | 614289 |
| Entrez | 80343 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 5 protein_coding_CDS_not_defined, 4 protein_coding, 3 nonsense_mediated_decay
ENST00000284951, ENST00000378072, ENST00000423870, ENST00000473203, ENST00000475649, ENST00000476952, ENST00000477435, ENST00000482196, ENST00000486903, ENST00000492548, ENST00000495437, ENST00000646153
RefSeq mRNA: 3 — MANE Select: NM_025229
NM_001271539, NM_001363752, NM_025229
CCDS: CCDS59443, CCDS86933
Canonical transcript exons
ENST00000284951 — 20 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001932979 | 13990477 | 13990614 |
| ENSE00003460729 | 13859262 | 13859434 |
| ENSE00003462972 | 13876038 | 13876115 |
| ENSE00003475355 | 13913782 | 13913944 |
| ENSE00003489719 | 13866702 | 13866850 |
| ENSE00003517278 | 13870141 | 13870203 |
| ENSE00003529382 | 13886288 | 13886442 |
| ENSE00003545620 | 13888459 | 13888512 |
| ENSE00003546432 | 13869503 | 13869590 |
| ENSE00003547710 | 13877520 | 13877588 |
| ENSE00003550543 | 13887942 | 13888001 |
| ENSE00003551744 | 13865167 | 13865241 |
| ENSE00003563765 | 13956076 | 13956131 |
| ENSE00003572236 | 13865349 | 13865514 |
| ENSE00003581354 | 13919021 | 13919123 |
| ENSE00003583289 | 13887769 | 13887850 |
| ENSE00003600785 | 13885347 | 13885403 |
| ENSE00003646456 | 13850191 | 13850319 |
| ENSE00003664542 | 13931603 | 13931771 |
| ENSE00003899974 | 13849247 | 13849604 |
Expression profiles
Bgee: expression breadth ubiquitous, 140 present calls, max score 86.54.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2966 / max 40.2723, expressed in 76 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 186474 | 0.2381 | 57 |
| 186473 | 0.0553 | 16 |
| 186475 | 0.0033 | 3 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.54 | gold quality |
| sperm | CL:0000019 | 83.53 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 78.79 | gold quality |
| left testis | UBERON:0004533 | 75.57 | gold quality |
| right testis | UBERON:0004534 | 75.10 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 74.56 | gold quality |
| testis | UBERON:0000473 | 74.25 | gold quality |
| left uterine tube | UBERON:0001303 | 70.65 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 70.46 | gold quality |
| popliteal artery | UBERON:0002250 | 69.81 | gold quality |
| tibial artery | UBERON:0007610 | 69.78 | gold quality |
| body of uterus | UBERON:0009853 | 69.34 | gold quality |
| right coronary artery | UBERON:0001625 | 66.42 | gold quality |
| myometrium | UBERON:0001296 | 66.01 | gold quality |
| aorta | UBERON:0000947 | 63.82 | gold quality |
| left coronary artery | UBERON:0001626 | 62.33 | gold quality |
| coronary artery | UBERON:0001621 | 61.45 | gold quality |
| ectocervix | UBERON:0012249 | 60.52 | gold quality |
| apex of heart | UBERON:0002098 | 58.91 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 58.53 | gold quality |
| adipose tissue | UBERON:0001013 | 58.28 | gold quality |
| fallopian tube | UBERON:0003889 | 57.17 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 57.06 | gold quality |
| endocervix | UBERON:0000458 | 56.75 | gold quality |
| right ovary | UBERON:0002118 | 56.43 | gold quality |
| thoracic aorta | UBERON:0001515 | 56.16 | gold quality |
| ascending aorta | UBERON:0001496 | 56.15 | gold quality |
| left ovary | UBERON:0002119 | 55.25 | gold quality |
| ovary | UBERON:0000992 | 55.16 | gold quality |
| superficial temporal artery | UBERON:0001614 | 55.06 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.88 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Sel1l2 | ENSMUSG00000074764 |
| rattus_norvegicus | Sel1l2 | ENSRNOG00000004852 |
| caenorhabditis_elegans | WBGENE00004759 |
Paralogs (4): SEL1L (ENSG00000071537), DELE1 (ENSG00000081791), SEL1L3 (ENSG00000091490), LRP2BP (ENSG00000109771)
Protein
Protein identifiers
Protein sel-1 homolog 2 — Q5TEA6 (reviewed: Q5TEA6)
Alternative names: Suppressor of lin-12-like protein 2
All UniProt accessions (6): Q5TEA6, A0A2R8Y3T2, A0A2R8YF92, C9JNX3, F8WE69, H7C4S6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane. Cell projection. Cilium. Nucleus speckle.
Similarity. Belongs to the sel-1 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5TEA6-1 | 1 | yes |
| Q5TEA6-2 | 2 |
RefSeq proteins (3): NP_001258468, NP_001350681, NP_079505* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006597 | Sel1-like | Repeat |
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR050767 | Sel1_AlgK | Family |
Pfam: PF08238
UniProt features (20 total): repeat 11, sequence variant 2, topological domain 2, signal peptide 1, chain 1, glycosylation site 1, splice variant 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TEA6-F1 | 84.89 | 0.61 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 34
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 40 (showing top):
GOBP_RESPONSE_TO_NITROGEN_COMPOUND, GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_ERAD_PATHWAY, IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR, GOBP_PROTEIN_CATABOLIC_PROCESS, GOCC_NUCLEAR_SPECK, GOCC_NUCLEAR_BODY, GOCC_RIBONUCLEOPROTEIN_GRANULE, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOBP_PROTEOLYSIS, GOCC_CILIUM, GOCC_ORGANELLE_SUBCOMPARTMENT, RATTENBACHER_BOUND_BY_CELF1
GO Biological Process (1): ERAD pathway (GO:0036503)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (6): endoplasmic reticulum membrane (GO:0005789), cilium (GO:0005929), nuclear speck (GO:0016607), nucleus (GO:0005634), membrane (GO:0016020), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| proteasomal protein catabolic process | 1 |
| response to endoplasmic reticulum stress | 1 |
| response to chemical | 1 |
| binding | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| nuclear ribonucleoprotein granule | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
610 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SEL1L2 | GAGE12H | A6NDE8 | 540 |
| SEL1L2 | C14orf119 | Q9NWQ9 | 518 |
| SEL1L2 | GAGE12B | A1L429 | 474 |
| SEL1L2 | LRP2BP | Q9P2M1 | 446 |
| SEL1L2 | TMEM125 | Q96AQ2 | 408 |
| SEL1L2 | FAM168B | A1KXE4 | 394 |
| SEL1L2 | SYVN1 | Q86TM6 | 364 |
| SEL1L2 | FAM168A | Q92567 | 362 |
| SEL1L2 | OS9 | Q13438 | 361 |
| SEL1L2 | CDC50B | Q3MIR4 | 350 |
| SEL1L2 | CDC50A | Q9NV96 | 347 |
| SEL1L2 | IQSEC2 | Q5JU85 | 343 |
| SEL1L2 | CYB5R4 | Q7L1T6 | 341 |
| SEL1L2 | PHF21A | Q96BD5 | 339 |
| SEL1L2 | EDEM1 | Q92611 | 316 |
IntAct
6 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EZR | MACROD2 | psi-mi:“MI:0914”(association) | 0.350 |
| FGFR1 | NDUFA4 | psi-mi:“MI:0914”(association) | 0.350 |
| TYRO3 | HAX1 | psi-mi:“MI:0914”(association) | 0.350 |
| TOMM20 | NUDT19 | psi-mi:“MI:2364”(proximity) | 0.270 |
| EPHB4 | ABL2 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (5): SEL1L2 (Affinity Capture-MS), SEL1L2 (Proximity Label-MS), SEL1L2 (Affinity Capture-MS), SEL1L2 (Proximity Label-MS), SEL1L2 (Affinity Capture-MS)
ESM2 similar proteins: A0AVF1, A1L1K3, A4III8, A5PLI4, A6H6E9, A8JA42, E9Q6P5, P09913, Q06AN9, Q14DN9, Q2KHY7, Q2TBM9, Q32NR4, Q3U213, Q3V172, Q4R3N2, Q4R6M4, Q4R7Z9, Q4V7F0, Q569C2, Q57ZL2, Q5PR66, Q5RE52, Q5TEA6, Q5U2N8, Q5W5X9, Q5XI05, Q5ZKK3, Q60462, Q64112, Q64282, Q66GN3, Q6AYP3, Q6IND7, Q80VM3, Q80YE7, Q86TV6, Q86TZ1, Q8BGB2, Q8BS45
Diamond homologs: O13875, Q3V172, Q5TEA6, Q5XI05, Q80Z70, Q9C6B6, Q9ESM7, Q9LM25, Q9UBV2, Q9Z2G6, Q05787, Q10NT7, Q6FNV5, Q9USV0, P44277, P77296, D3ZTE0, O18733, O60449, O97507, P00748, P02751, P04937, P07589, P08169, P08253, P11276, P11717, P11722, P14780, P22897, P33434, P33436, P41245, P41246, P49259, P49260, P50282, P50757, P52176
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2426810 | NC_000020.10:g.(?13765715)(14308152_?)del | Pathogenic |
SpliceAI
3551 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:13865237:CTTTT:C | acceptor_gain | 1.0000 |
| 20:13886357:A:AC | donor_gain | 1.0000 |
| 20:13886358:C:CC | donor_gain | 1.0000 |
| 20:13887767:A:AC | donor_gain | 1.0000 |
| 20:13887768:C:CC | donor_gain | 1.0000 |
| 20:13887848:CCC:C | acceptor_gain | 1.0000 |
| 20:13887849:CCC:C | acceptor_gain | 1.0000 |
| 20:13931595:CTACT:C | donor_loss | 1.0000 |
| 20:13931596:TACTT:T | donor_loss | 1.0000 |
| 20:13931597:ACTT:A | donor_loss | 1.0000 |
| 20:13931598:CT:C | donor_loss | 1.0000 |
| 20:13931599:TTACA:T | donor_loss | 1.0000 |
| 20:13931600:TACAA:T | donor_loss | 1.0000 |
| 20:13931601:A:AC | donor_gain | 1.0000 |
| 20:13931601:A:C | donor_loss | 1.0000 |
| 20:13931602:C:A | donor_loss | 1.0000 |
| 20:13931602:C:CA | donor_gain | 1.0000 |
| 20:13931602:CA:C | donor_gain | 1.0000 |
| 20:13931602:CAA:C | donor_gain | 1.0000 |
| 20:13931602:CAAT:C | donor_gain | 1.0000 |
| 20:13931602:CAATG:C | donor_gain | 1.0000 |
| 20:13956071:TTTA:T | donor_loss | 1.0000 |
| 20:13956072:TTACC:T | donor_loss | 1.0000 |
| 20:13956073:TACC:T | donor_loss | 1.0000 |
| 20:13956075:C:A | donor_loss | 1.0000 |
| 20:13956129:TAG:T | acceptor_gain | 1.0000 |
| 20:13956132:C:CC | acceptor_gain | 1.0000 |
| 20:13850189:A:AC | donor_gain | 0.9900 |
| 20:13850190:C:CC | donor_gain | 0.9900 |
| 20:13850316:TGTC:T | acceptor_gain | 0.9900 |
AlphaMissense
4546 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:13865381:G:T | A513D | 0.998 |
| 20:13869517:C:T | G414D | 0.998 |
| 20:13885393:C:T | G304E | 0.998 |
| 20:13865403:C:G | A506P | 0.997 |
| 20:13870175:C:T | G378D | 0.997 |
| 20:13876049:C:G | A365P | 0.997 |
| 20:13885394:C:G | G304R | 0.997 |
| 20:13885394:C:T | G304R | 0.997 |
| 20:13885396:A:G | L303P | 0.997 |
| 20:13886314:C:G | A292P | 0.997 |
| 20:13865366:G:T | A518E | 0.996 |
| 20:13865462:G:T | A486D | 0.996 |
| 20:13869518:C:G | G414R | 0.996 |
| 20:13869554:C:G | A402P | 0.996 |
| 20:13869557:C:G | A401P | 0.996 |
| 20:13870190:C:T | G373D | 0.996 |
| 20:13865423:A:G | L499P | 0.995 |
| 20:13870176:C:G | G378R | 0.995 |
| 20:13877524:C:T | G341E | 0.995 |
| 20:13885381:A:G | L308P | 0.995 |
| 20:13888505:C:T | G186E | 0.995 |
| 20:13859299:A:G | L594P | 0.994 |
| 20:13865176:C:G | A546P | 0.994 |
| 20:13865179:C:G | A545P | 0.994 |
| 20:13865181:C:G | R544P | 0.994 |
| 20:13869578:C:G | A394P | 0.994 |
| 20:13870191:C:G | G373R | 0.994 |
| 20:13876069:G:T | A358D | 0.994 |
| 20:13877564:C:G | A328P | 0.994 |
| 20:13877585:C:G | A321P | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000002052 (20:13887063 G>A), RS1000029244 (20:13981069 C>T), RS1000076129 (20:13925337 G>A), RS1000076952 (20:13907484 G>A,C), RS1000088708 (20:13952691 T>G), RS1000113814 (20:13880067 A>T), RS1000130454 (20:13930194 T>C), RS1000168416 (20:13878463 T>C), RS1000169624 (20:13882781 A>C,G), RS1000170028 (20:13895267 A>C), RS1000175177 (20:13873554 G>T), RS1000195298 (20:13962136 C>T), RS1000223410 (20:13969559 G>A,C), RS1000230426 (20:13981990 T>C), RS1000232324 (20:13925577 A>G)
Disease associations
OMIM: gene MIM:614289 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009391_7 | Metabolite levels | 2.000000e-06 |
| GCST012490_470 | Femur bone mineral density x serum urate levels interaction | 7.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007813 | cotinine measurement |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| aflatoxin B2 | affects methylation | 1 |
| bisphenol S | decreases methylation | 1 |
| Fulvestrant | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.